Cullinan Pearl Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Cullinan Pearl General Information
Description
A medical program to create orally available small molecule for cancer treatment. The program creates a inhibitor that selectively targets cells expressing EGFR exon 20 insertion mutations while sparing cells expressing wild-type EGFR.
Contact Information
Corporate Office
- Cambridge, MA
- United States
Corporate Office
- Cambridge, MA
- United States
Cullinan Pearl Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cullinan Pearl Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cullinan Pearl FAQs
-
Where is Cullinan Pearl headquartered?
Cullinan Pearl is headquartered in Cambridge, MA.
-
What industry is Cullinan Pearl in?
Cullinan Pearl’s primary industry is Buildings and Property.
-
Is Cullinan Pearl a private or public company?
Cullinan Pearl is a Private company.
-
What is the current valuation of Cullinan Pearl?
The current valuation of Cullinan Pearl is .
-
What is Cullinan Pearl’s current revenue?
The current revenue for Cullinan Pearl is .
-
Who are Cullinan Pearl’s investors?
Cullinan Therapeutics has invested in Cullinan Pearl.
-
When was Cullinan Pearl acquired?
Cullinan Pearl was acquired on 21-Jun-2022.
-
Who acquired Cullinan Pearl?
Cullinan Pearl was acquired by Taiho Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process